Intermountain Health has announced an expanded partnership with Story Health to “increase patient access to Intermountain’s…cardiology care.”
A pilot program had already been launched by Intermountain and Story Health in January 2023 “for patients with a new heart failure diagnosis.” Heart failure is expected to “grow by more than 25% by 2030.” However, “getting patients on optimized medication, known as guideline directed medical therapy (GDMT), has been shown to increase life expectancy of heart failure patients up to five years and can reduce hospitalizations by more than 70 percent.”
The pilot program showed “significant clinical improvement, including an increase in achieving medication optimization (GDMT) – with 80% of those medication changes handled without a clinic visit.” It also showed “significant improvement in quality-of-life scores” and “free[d] up an average of three clinic appointment slots for every enrolled patient.”
The Intermountain and Story Health partnership is also expanding to “include patients with hypertension.”
